When will vyzulta go generic?

Vyzulta (latanoprostene bunod ophthalmic solution) is under OTC?—sorry, it’s actually a prescription eye drop product. As of my latest general knowledge, I don’t have a guaranteed, finalized “exact month/year” date for when Vyzulta will go generic, because that depends on:

• Patent expirations (and any patent litigation settlements/extensions)
• FDA exclusivity periods (if any still apply)
• When the first generic/“authorized” version is approved and launched

What I can do

If you tell me your country (US, Canada, etc.) and whether you mean generic vs. “authorized” equivalents, I can narrow it down and point you to the exact sources to check (FDA Orange Book / patent listings).

Quick self-check (best source)

For the United States, the most reliable place is the FDA “Orange Book” entry for Vyzulta—look for:

• Patent expiration dates
• Hatch-Waxman “listed patents”
• Any generic applications that have been filed/approved

If you reply with what country you’re in, I’ll guide you to the right lookup and interpret what it means for “when generic.”